Airbus is to pay an estimated €3 billion in fines and penalties to Britain, France and America after plea-bargaining its way out of multinational investigations in to long-running accusations of bribery and corruption.
Retail sales fell flat this month as the gloom surrounding the festive period spread into the new year. According to the CBI, sales volumes were unchanged in the year to January and retailers expect the stagnation to continue into February.
Crest Nicholson Holdings (CRST)‘s new chief executive has pledged to return the company to its place as “one of the UK’s leading housebuilders” after the company reported a sharp fall in annual profit.
Stephen Clarke, the former boss of WH Smith, has landed a new chief executive role at Europe’s biggest vet chain in a move that reunites him with Kate Swann, his predecessor at WH Smith. He is joining IVC Evidensia, which has 1,371 veterinary clinics in 11 countries employing 19,000 people.
Disappointing sales of a blockbuster cancer drug and declining revenue from a pain relief medication lay behind the quarterly loss reported by Pfizer today.
A broker to Finablr PLC (FIN) has cut its target share price for the struggling foreign exchange group below the level at which it was floated less than a year ago.
Halma (HLMA) has moved swiftly to seal its first acquisitions of the year, snapping up two businesses for a combined initial price of £80 million.
A British private equity group is hoping to raise £200 million for a new investment trust that will target social and renewable infrastructure and property. Cabot Square Capital is preparing to list Cabot Square Alternatives on the main market of the London Stock Exchange.
AstraZeneca (AZN) sells rights to older drugs in Atnahs Pharma deal. One of Britain’s biggest drugs companies has offloaded a package of blood pressure medicines for up to $390 million as it focuses on new potential blockbusters.
The government has brought in the same turnaround advisers used during the collapse of Thomas Cook to counsel ministers on how much cash they should inject into Flybe.
